May 25, 2017
Highlights at the 2017 AUA Annual Meeting in Boston, Ma
The Center for Prostate Disease Research (CPDR) multi-disciplinary team - together with collaborators - presented six abstracts in podium and moderated poster presentations at the American Urological Association (AUA) Annual Meeting, May 12-16, 2017, Boston, MA. The team was co-led by COL Inger Rosner, MD, CPDR Director and Professor of the Department of Surgery, Uniformed Services University of the Health Sciences (USU) and the Walter Reed National Military Medical Center (WRNMMC); Dr. Shiv Srivastava, CPDR Co-Director and Professor in the Department of Surgery at USU and WRNMMC; Dr. Albert Dobi and Dr. Gyorgy Petrovics, Associate Directors, Basic Science Research Program, CPDR, Department of Surgery , USU and WRNMMC; and Dr. Jennifer Cullen, Director of Epidemiology Research Program, CPDR, Department of Surgery, USU.
The 2017 AUA Meeting in Boston, Ma
Poster Presentations
Dr. Taduru Sreenath presented a poster titled: Ets Related Gene Driven Androgen Receptor Aggregation is a Key Regulator of Endoplasmic Stress During Prostate Carcinogenesis, a collaborative study with complementary expertise of investigators from CPDR/USU/WRNMMC, JPC, FHCRC, UMBC institutions. The new insights into the cancer initiating mechanisms of ERG, the most common early oncogene in prostate cancer, may provide new therapeutic opportunities targeting the disease at early stages. These findings are published in Scientific Reports, Nature Publishers (http://www.nature.com/articles/s41598-017-01187-4).
Dr. Gyorgy Petrovics presented a poster titled: Development of a Prostate Cancer Gene Expression Panel to Address Racial Differences of Molecular Alterations in Prostate
Dr. Indu Kohaar presented a poster titled: Association of Common Genetic Variants with TMPRSS2-ERG Fusion Status in Prostate Cancer, a collaborative study with Dr. Matthew Freedman at Dana-Farber Cancer Institute, Boston, MA.
Dr. Ahmed Mohamed presented a poster titled: Structure-Activity Relationship Studies of ERGi-USU, a Highly Selective Inhibitor for ERG positive Prostate Cancer Cells Structure-Activity Relationship Studies of ERGi-USU, a Highly Selective Inhibitor for ERG positive Prostate Cancer Cells, a collaborative study with Dr. Sanjay Malhotra of Stanford University, and Dr Meera Srivastava and Dr. Clifton Dalgard of the Uniformed Services University of the Health Sciences.
Dr. Carolyn Salter presented a poster titled: Alkaline Phosphatase Velocity Predicts Metastasis among Prostate Cancer Patients who Experience Biochemical Recurrence after Radical Prostatectomy
Dr. William Gesztes podium presentation title was: p53 focal protein expression in primary prostate tumors and lymphatic vessel invasion predict biochemical recurrence and metastatic progression
The AUA meeting was highly successful for the CPDR team with great recognition from the national and international participants of AUA.
Dr. Gyorgy Petrovics and Dr. Indu Kohaar attending a podium presentation at the 2017 AUA meetinmg in Boston, Ma
Dr. Ahmed Mohamed presenting a synopsis of his poster presentation at the 2017 AUA meetinmg in Boston, Ma
